Medvedev signed a decree on provision of drugs for rare diseases

© RIA Novosti / Ekaterina to Stuckinarut in fotoreceptor of the government of the Russian Federation Dmitry Medvedev. Archival photoMedvedev signed a decree on provision of drugs for rare diseases© RIA Novosti / Ekaterina to Stuckinarut the image Bank

Prime Minister Dmitry Medvedev signed a decree defining the rules for the supply of medicines in the framework of the treatment of rare diseases, which will be expanded next year.

«Next year we, as agreed, expanding the Federal program on the so-called diseases, that is diseases rare and heavy enough that require expensive treatment», — said Medvedev at a meeting with Deputy Prime Ministers on Monday.

He said that we are talking about very significant money. «It is clear that many people have that kind of money, do not possess. We provide such patients with medicines at the expense of the Federal budget. Let’s face it: somewhere better, somewhere worse,» — said the Prime Minister.

«I signed a government resolution that defines rules to ensure that patients with such drugs and a number of organizational issues», — informed the head of the Cabinet.

The corresponding document has been published on the website of the Cabinet. Also approved the rules of conducting the Federal register of persons suffering from these rare diseases, the report said. The decision comes into force from 1 January 2019, the document States.

For its part the Vice Prime Minister Tatyana Golikova has reminded that for the purchase of medicines for the treatment of five diseases, which will expand the program by 10 billion rubles annually in the years 2019-2021. «Thus, the most sensitive and most expensive diseases we take on the level of Federal regulation,» she added.

Golikova said that signed by the head of the government resolution «is necessary in order to promptly organize the work on centralized procurement, bidding process and to provide citizens with these medicines from January 1, 2019».

In Russia at the expense of the Federal budget centrally purchased medicinal products for patients with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissue, multiple sclerosis, and patients undergoing transplantation of organs or tissues.

Russian President Vladimir Putin in August signed a law expanding the list of rare (orphan) diseases. The act seeks to transfer the powers to organise the provision of medicines of patients, haemolytic uraemic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis (types I, II, VI) the authority of the Federal Executive body, responsible for drafting and implementing state policy and normative legal regulation in the sphere of health.

Earlier, Putin said that from next year on medicines for patients with rare diseases will be additionally allocated 10 billion rubles.